You can now sell AI-generated artwork on Adobe Stock.
, the company says that the choice to allow generative AI onto its platform came after it “deeply considered” questions of ethics and proper use of the technology. The result it that while it is accepting artwork created with AI, it has also created a new submission policy that it believes will ensure generated artwork is used responsibly by creators and customers both.
“Properly built, used, and disclosed to viewers, generative AI can be a powerful tool to enhance creativity, accelerating the creative process to benefit both consumers of digital assets and the community of contributors who produce those assets.”
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Exclusive: Adobe will sell AI-made stock imagesThe software giant sees a future in which designers and artists collaborate with AI systems.
Lire la suite »
These Texas donors are going big for Herschel Walker and Raphael WarnockSee the top Texas contributors to the Warnock and Walker campaigns
Lire la suite »
Comcast Stock Gets Upgrade Even Though Analyst Is “Bearish on NBCU”'The media sector is heading into a very challenging period of weaker streaming results and much faster linear degradation,' says Wells Fargo's Steven Cahall. But the entertainment unit 'can leverage Comcast's strong balance sheet opportunistically.'
Lire la suite »
Tesla Stock Slumps After Company Reportedly Cuts Model Y Production From Shanghai PlantThe plan to cut production comes after delivered more than 100,000 from its Shanghai plant for the first time in November.
Lire la suite »
Tesla Stock Slumps After Company Reportedly Cuts Model Y Production From Shanghai PlantTesla’s shares fell in early trading on Monday following reports that the company will slash production of the Model Y from its Shanghai plant as the electric vehicle maker faces a slump in demand in China.
Lire la suite »
Goldman Sachs says this biotech stock can double on treatment against common childhood brain tumorThe firm said positive clinical data in the first quarter could serve as a catalyst for the stock.
Lire la suite »